Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Rosing

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004
Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsiaAnnemiek W Nap, Karly Hamulyak, Rene van Oerle, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 21, 2006
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosusEelco W Meesters, Hjalmar Hansen, Henri M H Spronk, et al.
The Journal of Biological Chemistry|May 3, 2011
Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivoHeather K Kroh, Peter Panizzi, Svetlana Tchaikovski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal womenMarinka S Post, M Christella, L G D Thomassen, et al.
British Journal of Haematology|April 9, 2005
Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein CMonica Galli, George M Willems, Jan Rosing, et al.
Haematologica|October 14, 2003
Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V poolM Christella L G D Thomassen, Elisabetta Castoldi, Guido Tans, et al.
Human Reproduction (Oxford, England)|November 13, 2004
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogensHuib A A M van Vliet, Marijke Frolich, M Christella, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2004
Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generationKristof Vanschoonbeek, Marion A H Feijge, Martine Paquay, et al.
Thrombosis and Haemostasis|February 15, 2013
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPIMarjolein Raps, Frans M Helmerhorst, Kathrin Fleischer, et al.
Thrombosis Research|October 16, 2007
Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeidenHuib A A M van Vliet, Sharon P Rodrigues, Marieke N E Snieders, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004
Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsiaAnnemiek W Nap, Karly Hamulyak, Rene van Oerle, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 21, 2006
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosusEelco W Meesters, Hjalmar Hansen, Henri M H Spronk, et al.
The Journal of Biological Chemistry|May 3, 2011
Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivoHeather K Kroh, Peter Panizzi, Svetlana Tchaikovski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal womenMarinka S Post, M Christella, L G D Thomassen, et al.
British Journal of Haematology|April 9, 2005
Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein CMonica Galli, George M Willems, Jan Rosing, et al.
Haematologica|October 14, 2003
Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V poolM Christella L G D Thomassen, Elisabetta Castoldi, Guido Tans, et al.
Human Reproduction (Oxford, England)|November 13, 2004
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogensHuib A A M van Vliet, Marijke Frolich, M Christella, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2004
Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generationKristof Vanschoonbeek, Marion A H Feijge, Martine Paquay, et al.
Thrombosis and Haemostasis|February 15, 2013
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPIMarjolein Raps, Frans M Helmerhorst, Kathrin Fleischer, et al.
Thrombosis Research|October 16, 2007
Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeidenHuib A A M van Vliet, Sharon P Rodrigues, Marieke N E Snieders, et al.
Pageof 8